Assessment of cognition enhancing effect of shvetajiraka on cognitive impairment in post menopausal women.

Assessment of Medhya Karma of Shvetajiraka (Cuminum cyminum Linn.) on cognitive impairment in post-menopausal women- A randomised clinical trial.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042445

Enrollment

Registered

2022-05-11

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F068- Other specified mental disorders due to known physiological condition

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A.Women who had attained menopause at least 4 years back and have memory complaints with MMSE score less than 24. B. Informed consent from the patient showing her willingness to participate in study.

Exclusion criteria

Exclusion criteria: 1.Patient who have reduced cognitive function as a result of trauma, surgery and due to any organic lesion 2.Patient not willing to sign informed consent. 3.Patient suffering from delusion or any other psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
Improvement (at least 2 points)in the score of MMSE.Timepoint: Outcome will be assessed at base line,4 weeks and 8 weeks	—

Secondary

Measure	Time frame
Improvement in quality of manas bhava. For it positive and negative emotions will be assessed on basis of already validated quesstionnaire.Timepoint: It will be assessed at baseline, 4 weeks and 8 weeks.	—

Countries

India

Contacts

Public ContactDr Swati Yadav

All India institute of Ayurveda

director@aiia.gov.in9958817145

Outcome results